Opko Health OPK unveils its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the earnings announcement.
Earnings and Revenue
Analysts are predicting Opko Health will report a loss of 11 cents per share on revenue of $225.07 million.
Opko Health EPS in the same period a year ago was a loss of 1 cent. Sales were $263.70 million. Sales would be down 14.65% on a year-over-year basis. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
| Quarter | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
| EPS Estimate | -0.090 | -0.09 | -0.08 | -0.07 |
| EPS Actual | -0.140 | -0.13 | -0.05 | -0.01 |
Stock Performance
Over the past 52-week period, shares of Opko Health have declined 67.06%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.
Analysts have adjusted their estimates lower for EPS and revenues over the past 90 days. The most common rating from analysts on Opko Health stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Opko Health is scheduled to hold the call at 4:30 p.m. ET and can be accessed here: https://edge.media-server.com/mmc/p/b4bq7t39
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
